chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dyschezia, Taste disorder, Vision blurred
Clinical narrative: A little bladder problems; urge to go to the bathroom/it's slowly goes out but I need to keep pushing and press to get the rest out mostly at night time; discomfort over the hair line; smell, face and blurry eye symptoms; smell, face and blurry eye symptoms/Blurry vision; taste foully taste, taste like chemical in something I eat; urge to go to the bathroom/it's slowly goes out but I need to keep pushing and press to get the rest out mostly at night time; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 60-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: Not reported), via an unspecified route of administration, administered in right arm on 07Apr2021 (at the age of 60-year-old) as DOSE 2, SINGLE for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number : Not reported), via an unspecified route of administration, administered in right arm on 16Mar2021 (at the age of 60-year-old) as DOSE 1, SINGLE for Covid-19 immunisation. She took the shot on last month on the 07Apr 2021, and at least a week after it got stronger. On 2021, the patient experienced a little bladder problems, urge to go to the bathroom/it's slowly goes out but she need to keep pushing and press to get the rest out, mostly at night time, discomfort over the hair line, smell, face and blurry eye symptoms and taste foully taste, taste like chemical in something she eat. Treatment not received for the adverse event. The patient underwent lab tests and procedures which included blood test: normal, everything look fine. They also took urine sample but not hear for the urine sample. (Further not clarified hence, not captured). Outcome of all the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Pain, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Itch, burn and sore after the shot and Arm is itching and burning, where she got her injection yesterday; Itch, burn and sore after the shot and Arm is itching and burning, where she got her injection yesterday; Itch, burn and sore after the shot; My wife is having allergies; This is a spontaneous report from a contactable consumer.   A 45-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 06May2021, (age at vaccination: 45 years), as dose 1, single dose for COVID-19 immunisation. The patient's medical history included blood pressure high. The patient's concomitant medications reported were several. On an unspecified date, the patient had Itch, burn and sore after the shot and Arm is itching and burning, where she got her injection yesterday. The reporter wanted to know whether we have itch and burn after the shot if its very sore, wife (patient) got this (Covid-19 vaccine). The reporter stated that she was taking several concomitant medications. The patient did not take any treatment for event. The reporter stated that his wife was having allergies. She said her arm was itching and burning, where she got her injection yesterday. Outcome of the events were unknown.  Follow-up attempts are completed. Information about lot/batch number cannot be obtained.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Decreased appetite, Feeling cold, Headache, Hyperhidrosis
Clinical narrative: feeling sick; sweating; Headache; Have no appetite; her every part of her body is cold; fever of 101*F; This is a spontaneous case received from a contactable consumer. This consumer (patient mother) reported for a 17-year-old female patient (reporter daughter). A 17-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9267, Expiry date: Unknown), via an unspecified route on an unspecified arm on 08May2021 (age at vaccination 17-year-old) as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were reported as none. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EM9810), via an unspecified route administered on 17Apr2021 (age at vaccination: 17-year-old), as a single dose for COVID-19 immunization and experienced no side effects. After the second dose, patient had a fever of 101*F later that evening (08May2021) and on Sunday (09May2021). She mentioned that fever broke when she was given ibuprofen and water, but it came back today with 99.9*F (10May2021). She was also given cold patches for her headaches. She is asking how long these side effects last and how long patient gonna have a fever and feeling sick as reporter did not want her to take to the doctor. According to the reporter on an unspecified date, patient also experienced no appetite, every part of her body was cold so far reporter can see it, she was sweating, so reporter was just fighting to break that up high fever, but mother was wondering if it was not, if her fever still high again tomorrow in the morning when we wake up it was best for mother to take her to the emergency room. The patient underwent lab tests and procedures which included body temperature: 101 Fahrenheit on 08May2021 and 99.9 Fahrenheit on 10May2021. Therapeutic measures were taken included treatment with ibuprofen for fever and cold patch on the head for headache. Patient was still experiencing events (not specified) and clinical outcome of the events was persisting.  No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pyrexia
Clinical narrative: feeling sick; sweating; Headache; Have no appetite; her every part of her body is cold; fever of 101*F; This is a spontaneous case received from a contactable consumer. This consumer (patient mother) reported for a 17-year-old female patient (reporter daughter). A 17-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9267, Expiry date: Unknown), via an unspecified route on an unspecified arm on 08May2021 (age at vaccination 17-year-old) as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were reported as none. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EM9810), via an unspecified route administered on 17Apr2021 (age at vaccination: 17-year-old), as a single dose for COVID-19 immunization and experienced no side effects. After the second dose, patient had a fever of 101*F later that evening (08May2021) and on Sunday (09May2021). She mentioned that fever broke when she was given ibuprofen and water, but it came back today with 99.9*F (10May2021). She was also given cold patches for her headaches. She is asking how long these side effects last and how long patient gonna have a fever and feeling sick as reporter did not want her to take to the doctor. According to the reporter on an unspecified date, patient also experienced no appetite, every part of her body was cold so far reporter can see it, she was sweating, so reporter was just fighting to break that up high fever, but mother was wondering if it was not, if her fever still high again tomorrow in the morning when we wake up it was best for mother to take her to the emergency room. The patient underwent lab tests and procedures which included body temperature: 101 Fahrenheit on 08May2021 and 99.9 Fahrenheit on 10May2021. Therapeutic measures were taken included treatment with ibuprofen for fever and cold patch on the head for headache. Patient was still experiencing events (not specified) and clinical outcome of the events was persisting.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Scar, Scratch
Clinical narrative: Itching is relentless; Skin is all scratched up; Creating scars; Rash all over back, neck, down to butt; This is a spontaneous report from a contactable consumer or other Non Health Care Professional.    A patient of unspecified age and gender received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 08Apr2021, as DOSE 2, SINGLE for covid-19 immunisation. The patient had received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date, as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced Creating scars, Skin is all scratched up and Itching is relentless. On 08Apr2021, the patient experienced rash all over back, neck, down to butt (rash). At the time of reporting, the outcome of the events were unknown.   No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Pruritus, Rash
Clinical narrative: Itching is relentless; Skin is all scratched up; Creating scars; Rash all over back, neck, down to butt; This is a spontaneous report from a contactable consumer or other Non Health Care Professional.    A patient of unspecified age and gender received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 08Apr2021, as DOSE 2, SINGLE for covid-19 immunisation. The patient had received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date, as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced Creating scars, Skin is all scratched up and Itching is relentless. On 08Apr2021, the patient experienced rash all over back, neck, down to butt (rash). At the time of reporting, the outcome of the events were unknown.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Infectious mononucleosis
Clinical narrative: Mononucleosis; This is a spontaneous report from a contactable consumer. This consumer (patient's parent) reported that:  An 18-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced mononucleosis. Stated that the reported had a child who got the first shot, she was 18 she got the first shot of Pfizer and in between getting the second shot she developed Mononucleosis. The reporter was concerned whether the patient should go for the second shot. The outcome of the event was unknown.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Glossodynia, Hypersensitivity, Oral discomfort, Oral pain, Pyrexia
Clinical narrative: she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; This is a spontaneous report from a contactable consumer (herself). A 54-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 07May2021 15:18, (age at vaccination: 54 years), as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE solution for injection, Batch/Lot number was not reported, age at vaccination: 54 years), dose 1 via an unspecified route of administration on 07May2021 15:18), as DOSE 1, SINGLE for covid-19 immunisation and experienced unwell, headache and bone pain. The patient experienced experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth on an unspecified date. The clinical outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Tongue discomfort
Clinical narrative: she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; she experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth; This is a spontaneous report from a contactable consumer (herself). A 54-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 07May2021 15:18, (age at vaccination: 54 years), as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE solution for injection, Batch/Lot number was not reported, age at vaccination: 54 years), dose 1 via an unspecified route of administration on 07May2021 15:18), as DOSE 1, SINGLE for covid-19 immunisation and experienced unwell, headache and bone pain. The patient experienced experienced fever and allergic reactions in the form of painful and burning lesions on tongue, palate and mouth on an unspecified date. The clinical outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough
Clinical narrative: getting worse after my second shot; They gave me antacid pills, not working either; Chronic cough that is not stopped; had nonstop cough; This is a spontaneous report from a contactable consumer or other non hcp.  A 57-years-old female patient received bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot Number was unknown,Expiration Date: Unknown), dose 1 Single, via an unspecified route of administration, administer at right arm on 04Mar2021 for covid-19 immunisation and bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot Number: EW0153 ; Expiration Date: Unknown), dose 2 Single, via an unspecified route of administration,administer at right arm on 08Feb2021 for covid-19 immunisation.  Medical history included thyroid disorder from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID) For years, it's been for years, I just don't remember, it's been so long, 20 years I guess and for Thyroid.  The patient states that started coughing after the first one periodically and I had nonstop cough since I got my second one. I've been to the doctor twice patient also added that It was getting worse after my second shot. It got really bad. I am coughing less now. It's still persisting."Patient also state that I've tried inhalers, didn't work they gave me antacid pills, not working. The outcome of  all events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: pain in the arm; she had some tiredness soon; This is a spontaneous report from a contactable consumer (patient herself). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation (at the age of 74years).  Medical history included ongoing bladder infections and ulcer in her vaginal area. Concomitant medication(s) included estrogens conjugated (ESTROGENS CONJUGATED) taken for an unspecified indication.  The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation, Premarin Vaginal cream and Estradiol Vaginal Cream 0.01%. On 06May2021, the patient experienced pain in the arm and, she had some tiredness soon on an unspecified date in 2021. Patient stated, she was using Premarin Cream. She used it last night and this morning when she urinated it smelled like formaldehyde. It stays like that for some time. She has had bladder infections and then thought something was wrong. She talked with her nurse who asked what medications and cream she was using. Then patient made the connection when she used it last night and it smelled like that this morning. Patient and her friend had the shot about 50 days ago. Her friend complained a day or so ago that her arm was hurting and then complained her elbow was hurting yesterday. She didn't think it was related to the vaccine. Then this morning patient's arm was hurting. She clarified shot as Pfizer COVID19 Vaccine and asked if arm pain that long after the vaccine been reported. Urine smelled like formaldehyde: started this morning, but it has happened in the past. It has been going on for 2 weeks since she started using it again. She had used Premarin before and stopped and went to another cream. She doesn't remember any side effects with the other cream. The other cream cost twice as much as Premarin. She states this has been an on going problem. She didn't want to use Premarin before and can't remember why. The Premarin cost 45 and the other cream is 90. Patient clarified the other cream she used was Estradiol Vaginal Cream 0.01%. She used Estradiol and had no issue at all. She bought two tubes and they last 6 months to a year each.  Then she stopped using it because she didn't want to spend the money. The outcome of both the events was unknown.  Follow up attempts are completed. No further information is expected.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Dry skin, Pruritus, Scar
Clinical narrative: blisters on different areas- arms, legs, chest and some on his back/get blisters all over his body; Has dry skin; Skin is itchy but not sure if its from the blisters; chest is the worst part of it and he has bad scars left from them; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for himself that,  A 85-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EW0172) (at the age of 85 years old), dose 2 via an unspecified route of administration, administered in arm left on 04May2021 as dose 2, single for covid-19 immunisation (age at the vaccination 85-years-old). Historical vaccine, the patient took first dose bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EB8737), dose 1 via an unspecified route of administration administered in arm left, on 04Apr2021 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient's first dose was on 04Apr2021, and he developed blisters on his chest that lasted for a month and did not resolve before receiving the second dose. He received his second shot on 04May2021. On an unspecified date in May 2021, he had blisters on different areas arms, legs, chest and some on his back. His chest was the worst part of it and he had bad scars left from them. Some were berry small and some were quite large, smaller than a penny about half an inch by quarter inch. The small ones were like a ball point pen. He had dry skin and tried to keep lotion on them. Skin was itchy but not sure if it was from the blisters. He also had one blister on his arm and one on his leg. He has burst some, but he saw his doctor told him not to burst anymore and was prescribed some cream that he still had to pick up from the pharmacy. He saw his family doctor and he couldn't find any reason why they would be developing. Treatment for the events was received. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer suspect. There was no prior vaccination within four weeks. The relevant tests were reported. The outcome for the events were unknown.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Extremely fatigue for 4 days; Heavy sweats; Loss of appetite; Headache; Dizzy; Continuing vertigo for longtime today is 5th day; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 01May2021 at 15:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 10Apr2021 at 15:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 07:00, the patient experienced extremely fatigue for 4 days, heavy sweats, loss of appetite, headache, dizzy and continuing vertigo for long time, today was 5th day (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extremely fatigue for 4 days was resolved on 06May2021 at 07:00. The clinical outcome of the events heavy sweats, loss of appetite, headache, dizzy and continuing vertigo for long time today was 5th day was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Extremely fatigue for 4 days; Heavy sweats; Loss of appetite; Headache; Dizzy; Continuing vertigo for longtime today is 5th day; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 01May2021 at 15:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 10Apr2021 at 15:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 07:00, the patient experienced extremely fatigue for 4 days, heavy sweats, loss of appetite, headache, dizzy and continuing vertigo for long time, today was 5th day (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extremely fatigue for 4 days was resolved on 06May2021 at 07:00. The clinical outcome of the events heavy sweats, loss of appetite, headache, dizzy and continuing vertigo for long time today was 5th day was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Headache, Neck pain, Pain
Clinical narrative: Injection site soreness; Ache behind the eyes and like a sinus headache; It went down to the neck, shoulder and back and have whole body pain.; It went down to the neck, shoulder and back and have whole body pain.; It went down to the neck, shoulder and back and have whole body pain.; It went down to the neck, shoulder and back and have whole body pain.; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (Patient). A 58-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. Medical history included he lost his eye sight in service from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on an unspecified date (at the age of 58-years-old) as dose 1, single for COVID-19 immunisation and experienced injection site soreness. After the 2nd Pfizer covid vaccine patient had injections site soreness and 12 hours after in the middle of the night I started to ache behind the eyes and like a sinus headache then it went down to the neck, shoulder and back and have whole body pain on an unknown date. 10 hours after it began about 24 hours after the injection treatment was received for the events as 400 mg of ibuprofen without thinking about it. to minimize the aches and pains. Now patient worried he blunted the efficacy of the vaccine. Patient took the ibuprofen 24 hours after received the vaccine, 12 hours after had some symptoms. Patient took it 24 hours after the vaccination, 12 hours after the onset of symptoms. The outcome of the events was reported as unknown.  Description of complaint: Caller stated that 12 hours after symptoms he took ibuprofen and he didn't consider how it may blunt or depress the immune response. If it blunted or adversely effected the immune response to the vaccination. He has concerns about the actual level of immunity developed from the second dose and if it may have blunted the effects.  No follow up attempts are needed, No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site soreness; Ache behind the eyes and like a sinus headache; It went down to the neck, shoulder and back and have whole body pain.; It went down to the neck, shoulder and back and have whole body pain.; It went down to the neck, shoulder and back and have whole body pain.; It went down to the neck, shoulder and back and have whole body pain.; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (Patient). A 58-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. Medical history included he lost his eye sight in service from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on an unspecified date (at the age of 58-years-old) as dose 1, single for COVID-19 immunisation and experienced injection site soreness. After the 2nd Pfizer covid vaccine patient had injections site soreness and 12 hours after in the middle of the night I started to ache behind the eyes and like a sinus headache then it went down to the neck, shoulder and back and have whole body pain on an unknown date. 10 hours after it began about 24 hours after the injection treatment was received for the events as 400 mg of ibuprofen without thinking about it. to minimize the aches and pains. Now patient worried he blunted the efficacy of the vaccine. Patient took the ibuprofen 24 hours after received the vaccine, 12 hours after had some symptoms. Patient took it 24 hours after the vaccination, 12 hours after the onset of symptoms. The outcome of the events was reported as unknown.  Description of complaint: Caller stated that 12 hours after symptoms he took ibuprofen and he didn't consider how it may blunt or depress the immune response. If it blunted or adversely effected the immune response to the vaccination. He has concerns about the actual level of immunity developed from the second dose and if it may have blunted the effects.  No follow up attempts are needed, No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Severe chills; Severe headache; Severe nausea; Emesis; Mild myalgia; Moderate to severe fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to non-steroidal anti-inflammatory drugs (NSAIDs). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05May2021 at 05:00, the patient experienced severe chills, severe headache, severe nausea, emesis, mild myalgia and moderate to severe fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL) and bed rest. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's severe chills, severe headache, severe nausea, emesis, mild myalgia and moderate to severe fatigue were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Severe chills; Severe headache; Severe nausea; Emesis; Mild myalgia; Moderate to severe fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to non-steroidal anti-inflammatory drugs (NSAIDs). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05May2021 at 05:00, the patient experienced severe chills, severe headache, severe nausea, emesis, mild myalgia and moderate to severe fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL) and bed rest. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's severe chills, severe headache, severe nausea, emesis, mild myalgia and moderate to severe fatigue were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Dizziness, Influenza like illness, Myalgia
Clinical narrative: muscle pains; Light headedness/light headed; scratchy throat; cough; sore throat; chills; Body aches; flu like symptoms/he is sick or has a virus, not Covid, but like getting the flu or something; This is a spontaneous report from a Pfizer sponsored program via a contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Not reported, Expiration date: Unknown), via an unspecified route of administration on 29Apr2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Not reported, Expiration date: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient experienced muscle pains, light headedness or light-headed, scratchy throat, cough, sore throat, chills, body aches, flu like symptoms and he was sick or had a virus, not COVID, but like getting the flu or something on an unspecified date. It was reported that the patient developed symptoms 9-10 days after he received his second dose of the Pfizer COVID-19 vaccine. The outcome of the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Throat irritation
Clinical narrative: muscle pains; Light headedness/light headed; scratchy throat; cough; sore throat; chills; Body aches; flu like symptoms/he is sick or has a virus, not Covid, but like getting the flu or something; This is a spontaneous report from a Pfizer sponsored program via a contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Not reported, Expiration date: Unknown), via an unspecified route of administration on 29Apr2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Not reported, Expiration date: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient experienced muscle pains, light headedness or light-headed, scratchy throat, cough, sore throat, chills, body aches, flu like symptoms and he was sick or had a virus, not COVID, but like getting the flu or something on an unspecified date. It was reported that the patient developed symptoms 9-10 days after he received his second dose of the Pfizer COVID-19 vaccine. The outcome of the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Myalgia
Clinical narrative: Muscle pain; Joint pain; Back pain; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced muscle pain, joint pain, and back pain. As reported clinical course: Patient was wondering how long pain will last. She says that she called about a week ago. She wasn't aware that muscle and joint pain were associated with the Covid Vaccine pretty strongly. States that some of the pain was continuing, the joint pain was gone. States that the severe back and joint pain scared her so much. She found out it was normal. Her Nurse Practitioner said that the pain could be present for up to 3 weeks. States that if other people aren't effected like she has been they think it was all in the person's head. States she has been having to work through her pain as they are testing at school now and she cannot take off. She was also wondering what was in the vaccine that causes this side effect. This report was not related to a study or programme. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Cough, Dyspnoea, SARS-CoV-2 test
Clinical narrative: experiencing shortness of breath; cough; This is a spontaneous report from a contactable consumer or other non-health care professional reporting for wife (Patient).  A 27-year-old female patient received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Batch no/ Lot number: not reported) via an unknown route of administration on an unspecified date as dose 1, single for covid-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, patient experienced with shortness of breath and cough together, after her 1st dose of the vaccine 10 days before. Patient went to the doctor for the resulted events, and she tested for the Covid. Patient did not have these problems until she received her vaccination was reported as no. Investigation Assessment was not provided. On an unknown date, patient underwent lab tests and procedure which were evaluated blood pressure test with unknown results and a COVID test results negative for Sars-cov-2. Reporter mentioned that patient did not have these problems until she received her vaccination. They are evaluating a possible respiratory problem, but it was still too early to conclude. Patient was asking whether the reported events were side effect of vaccine. The outcome of the events was unknown.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Malaise, Nausea, Neck pain
Clinical narrative: extremely nauseous; short of breath; Very lightheaded/dizzy; feeling terrible; pain in her neck and jaw; pain in her neck and jaw; This is a spontaneous report received from a contactable consumer (patient).   A 52-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation: Solution for injection, Lot Number: unknown), via an unspecified route of administration on 08May2021 (age at vaccine 52-years-old) as dose 1, single for covid-19 immunization.The patient medical history and concomitant medications was not reported. On 09May2021, the patient experienced Very lightheaded/dizzy, very short of breath, extremely nauseous and on unknown date in 2021, the patient experienced pain in her neck and jaw, feeling terrible. It was reported that patient have been feeling terrible, extremely nauseous, short of breath, dizzy and reported pain in her neck and jaw. she was asking if she needs to go to the emergency room as she was not the type of person to seek medical attention even when she previously tore her ACL. she did not have a primary care provider. She referred to vaccination Provider or urgent care for additional guidance as caller stated she did not have a primary care provider she reported that she was one of those people that would like her death to be a surprise, so she doesn't go to the doctor or the emergency room. She stated that she does not know if this was something that was normal or if she should go to the doctor. The clinical outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in jaw
Clinical narrative: extremely nauseous; short of breath; Very lightheaded/dizzy; feeling terrible; pain in her neck and jaw; pain in her neck and jaw; This is a spontaneous report received from a contactable consumer (patient).   A 52-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation: Solution for injection, Lot Number: unknown), via an unspecified route of administration on 08May2021 (age at vaccine 52-years-old) as dose 1, single for covid-19 immunization.The patient medical history and concomitant medications was not reported. On 09May2021, the patient experienced Very lightheaded/dizzy, very short of breath, extremely nauseous and on unknown date in 2021, the patient experienced pain in her neck and jaw, feeling terrible. It was reported that patient have been feeling terrible, extremely nauseous, short of breath, dizzy and reported pain in her neck and jaw. she was asking if she needs to go to the emergency room as she was not the type of person to seek medical attention even when she previously tore her ACL. she did not have a primary care provider. She referred to vaccination Provider or urgent care for additional guidance as caller stated she did not have a primary care provider she reported that she was one of those people that would like her death to be a surprise, so she doesn't go to the doctor or the emergency room. She stated that she does not know if this was something that was normal or if she should go to the doctor. The clinical outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, SARS-CoV-2 antibody test
Clinical narrative: little lightheaded; tired; This is a spontaneous report from a contactable consumer via medical information team. A 76-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/ lot number was not reported), via an unspecified route of administration on 04Mar2021 as dose 1, single for COVID-19 immunization. The medical history included chronic lymphocytic leukaemia (CLL), he was diagnosed 14-15 months ago with CLL and had been taking Imbruvica 420mg/day. His WBC count was 16K and was 50-60% lymphocytes but now his bloodwork was good and controlled by Imbruvica. He also had dental, orthopaedic and heart issues. He had a spleen that was measuring 22cm and was pushing his stomach out. He then moved from to a private doctor and had moved from Stage 2 to Stage 0. He had had no side effects from the Imbruvica. The patient's concomitant medications were not reported. On 04Mar2021 after the first shot the patient felt a little lightheaded and then tired the same day. He also received his second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/ lot number was not reported) on 24Mar2021. On an unspecified date the patient underwent lab tests and procedures which included immunity test to check if he gained immunity to the shots like Corona IGG /Sars Covid 2 IGG spikes both came out negative. The first was an ABIGG, SPIKE S done two weeks after the vaccine and the reading was a little arrow to the left less than 1. His doctor told him that this only shows recent infection. The second antibody test he had done four weeks after the vaccine was a CoV-2 IGG/IGM and the little arrow read to the left of 1.4. and then later were 0.04 and 0.02 readings. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.